相关实验视频

Updated: Aug 2, 2026

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

27.8K

转录基因分析确定了贝瓦西祖马布耐药性质母细胞瘤的潜在目标

Roshan Lodha1,2, Gaelle Muller-Greven2, Muhammad Asad Maqbool3

  • 1Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, USA.

Scientific reports
|October 22, 2025
PubMed
概括

具有高早期生长反应-1 (EGR1) 表达的质母细胞瘤 (GBM) 患者对贝瓦西祖马布治疗的反应不佳. 瘤中EGR1升高,血管生成增加和Ki67标记预测治疗失败,这表明EGR1是潜在的生物标志物.

关键词:
血管新生的产生.贝瓦西祖马布 (bevacizumab) 是一种药物.这就是CHRNA7的原因.欧洲农业基金会 (EGFR) 是一个基金.在 EGR1 里面,你会看到 EGR1 的位置.质母细胞瘤 (glioblastoma) 是一个在MGMT中,我们可以看到MGMT.在这里,我们可以使用PTEN.核武器的扩散性爱 性的性爱 性的性爱α7-nAChRR 是一个

更多相关视频

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma10:58

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma

Published on: February 22, 2015

13.4K
Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

5.9K

相关概念视频

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...